[HTML][HTML] 尼达尼布治疗特发性肺纤维化的长期疗效及安全性: 单中心参与INPULSIS 及INPULSIS ON 的系列病例分析

丁旻, 李佳旻, 洪群英, 毛若琳, 崔博, 马圆… - 复旦学报(医学版 …, 2022 - jms.fudan.edu.cn
… Long-term clinical efficacy and safety of nintedanib in the treatment of idiopathic pulmonary
fibrosis (IPF): case analysis of single center involved in INPULSIS and INPULSIS ON[J]. …

[HTML][HTML] Yangqing Chenfei formula (养清尘肺方) alleviates crystalline silica induced pulmonary inflammation and fibrosis by suppressing macrophage polarization

T Xinrong, HOU Runsu, LIU Xinguang… - Journal of Traditional …, 2023 - ncbi.nlm.nih.gov
… expiratory volume in the first 0.3 s, functional residual capacity… improved lung functions by
upregulating tidal volume, pause … , such as pirfenidone and nintedanib, can only relieve clinical …

Yangqing Chenfei formula (养清尘肺方) alleviates crystalline silica induced pulmonary inflammation and fibrosis by suppressing macrophage polarization

X TIAN, R HOU, X LIU, P ZHAO, Y TIAN… - … i tsa Chih Ying wen pan, 2023 - europepmc.org
… expiratory volume in the first 0.3 s, functional residual capacity… improved lung functions by
upregulating tidal volume, pause … , such as pirfenidone and nintedanib, can only relieve clinical …

肌纤维母细胞的凋亡逃避: 纤维化疾病的标志

B Hinz, D Lagares - zh-pdf.nature.com
… A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. …
Thannickal, VJ & Horowitz, JC Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proc. …